| Lee, Woo Yong |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel |
|
|
| Completed | 3 | 571 | Europe, Canada, US, RoW | NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel | NovoCure Ltd. | Pancreas Adenocarcinoma | 10/24 | 10/24 | | |
ASPIRE, NCT05254171: Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer |
|
|
| Recruiting | 2/3 | 600 | Europe, US, RoW | SBP-101, ivospemin, Nab-paclitaxel, Abraxane, Gemcitabine, Gemzar, Placebo | Panbela Therapeutics, Inc. | Pancreatic Cancer Metastatic, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Stage IV | 08/26 | 01/27 | | |
ACCENT, NCT05355298: AMP945 in Combination with Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer |
|
|
| Recruiting | 1/2 | 62 | RoW | AMP945 ascending doses, AMP945 RP2D | Amplia Therapeutics Limited | Pancreatic Cancer, PDAC, Pancreatic Ductal Adenocarcinoma | 05/25 | 05/25 | | |
| Recruiting | 1 | 18 | RoW | GB104(Level 1), GB104(Level 2), GB104(Level 3) | GI Biome, Inc. | Solid Tumor, Colorectal Cancer, Sigmoid Colon Cancer, Rectosigmoid Junction Cancer, Cancer, Rectal Cancer | 12/23 | 12/23 | | |
NCT05868070: Feasibility and Safety of In-bed Cycling/Stepping in Critically Ill Patients |
|
|
| Recruiting | N/A | 24 | RoW | Conventional rehabilitation plus multimodal exercise | Seoul National University Hospital | Critically Ill Patient, Intensive Care Unit Acquired Weakness | 12/24 | 12/24 | | |
NCT06363357: The Effect of a Muscle-mimicking, Fabric-type Shoulder Orthosis on Functional Movements of the Upper Limb in Patients With Duchenne Muscular Dystrophy |
|
|
| Recruiting | N/A | 30 | RoW | Shoulder orthosis | Seoul National University Hospital | Muscular Dystrophy, Duchenne, Orthotic Devices, Upper Extremity | 12/25 | 12/25 | | |
NCT06380049: Predicting Fall Risk in Stroke Patients Using a Machine Learning Model and Multi-Sensor Data |
|
|
| Not yet recruiting | N/A | 90 | NA | EMG Analysis Software | Seoul National University Hospital, Ministry of Trade, Industry & Energy, Republic of Korea | Stroke, Fall | 04/25 | 04/26 | | |
NCT06387459: Feasibility of Fabric Orthosis for Knee Support in Elderly Gait Improvement |
|
|
| Not yet recruiting | N/A | 30 | NA | Fabric-Type Knee Extensor Muscle-Mimicking Orthosis | Seoul National University Hospital, Ministry of Science and ICT | Gait, Fall, Orthotic Devices | 05/25 | 05/26 | | |
NCT05820815: Feasibility and Safety of In-bed Self-exercise in Patients With Subacute Stroke |
|
|
| Recruiting | N/A | 24 | RoW | in-bed self-exercises based on EMG-sensor feedback intervention | Seoul National University Hospital, Ministry of Trade, Industry & Energy, Republic of Korea | Stroke | 06/26 | 12/26 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
| Heo, Jung Ho |
| Recruiting | 4 | 492 | RoW | Prasugrel 5mg, Effient, Ticagrelor 60mg, Brillinta | Gyeongsang National University Hospital, U&I Corporation | Coronary Artery Disease | 06/21 | 06/22 | | |
ASSIST, NCT05529459: Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD |
|
|
| Recruiting | N/A | 2400 | RoW | Percutaneous Coronary Intervention | Seung-Whan Lee, M.D., Ph.D., Biotronik Korea Co., Ltd | Coronary Disease | 12/26 | 07/30 | | |
PROVE-DM, NCT05579626: Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus |
|
|
| Recruiting | N/A | 4000 | RoW | high-intensity statin arm, low-intensity statin plus ezetimibe | Seung-Whan Lee, M.D., Ph.D., Yuhan Corporation | Pre Diabetes, ASCVD | 12/27 | 12/27 | | |
NCT05258708: COVID-19 Vaccine Reactogenicity and Immunogenicity |
|
|
| Recruiting | N/A | 179 | RoW | mRNA-1273 COVID-19 vaccine | Korea University Guro Hospital, Catholic Kwandong University, Ajou University School of Medicine, Hallym University Kangnam Sacred Heart Hospital, Korea University Anam Hospital, Korean Center for Disease Control and Prevention | COVID-19, Vaccine Immune Response, Vaccine Adverse Reaction | 05/22 | 05/22 | | |
NCT05315856: Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine Platforms |
|
|
| Recruiting | N/A | 120 | RoW | either BNT162b2 or ChAdOx1 vaccine | Korea University Guro Hospital, Ajou University School of Medicine, Hallym University Kangnam Sacred Heart Hospital, Korean Center for Disease Control and Prevention | COVID-19 Vaccination, Inflammation, Vaccine Immune Response, Vaccine Adverse Reaction | 05/22 | 12/22 | | |
